Development Level

Tbio 2 | 10,625
Tclin 2 | 602

IMPC Term

abnormal bone mineralization 1 | 55
abnormal bone structure 1 | 131
abnormal coping response 1 | 12
abnormal lens morphology 1 | 73
decreased body weight 1 | 174
decreased bone mineral density 1 | 126
decreased lean body mass 1 | 195
decreased macrophage cell numb... 1 | 4
increased startle reflex 1 | 38
kinked tail 1 | 3
preweaning lethality, complete... 1 | 633

Disease

Pick disease 3 | 1,893
group 3 medulloblastoma 3 | 2,254
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
pediatric high grade glioma 3 | 2,712
psoriasis 3 | 6,685
Atopic dermatitis 2 | 944
Breast cancer 2 | 3,094
Cancer 2 | 2,346
Malignant hyperthermia 2 | 25
Renal Cell Carcinoma 2 | 199
Schizophrenia 2 | 501
acute quadriplegic myopathy 2 | 1,157
astrocytic glioma 2 | 2,241
atypical teratoid / rhabdoid tumor 2 | 4,369
cystic fibrosis 2 | 1,665
diabetes mellitus 2 | 1,663
glioblastoma 2 | 5,572
lung adenocarcinoma 2 | 2,713
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
oligodendroglioma 2 | 2,849
pancreatic cancer 2 | 2,300
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
posterior fossa group A ependymoma 2 | 1,511
subependymal giant cell astrocytoma 2 | 2,287
Adenoma 1 | 165
Alzheimer's disease 1 | 644
Amyloidosis 1 | 68
Amyotrophic Lateral Sclerosis 1 | 431
Carcinoma 1 | 2,147
Carcinoma of breast 1 | 11
Cerebrovascular disease 1 | 231
Colorectal Neoplasms 1 | 217
Crohn's disease 1 | 304
Duchenne muscular dystrophy 1 | 602
Epilepsy 1 | 346
Fibrodysplasia ossificans progressiva 1 | 17
Gaucher disease type 1 1 | 171
Heart disease 1 | 279
Hormone receptor positive malignant neoplasm of breast 1 | 10
Hypertension 1 | 287
Idiopathic scoliosis 1 | 29
Inflammatory Bowel Diseases 1 | 87
Intractable Eczema 1 | 5
Invasive aspergillosis 1 | 6
Left ventricular noncompaction 1 | 23
Legionnaires' disease 1 | 20
Liver transplant rejection 1 | 5
Long QT syndrome 1 | 52
Mammary Neoplasms 1 | 410
Mantle cell lymphoma 1 | 18
Multiple epiphyseal dysplasia 1 | 12
Multiple myeloma 1 | 1,327
Neurodegenerative disease 1 | 383
Otitis externa 1 | 9
Pancreatic Neuroendocrine Tumor 1 | 45
Pertussis 1 | 17
Prevention of Cardiac Transplant Rejection 1 | 14
Prevention of Kidney Transplant Rejection 1 | 16
Prevention of Liver Transplant Rejection 1 | 14
Prevention of Transplant Rejection 1 | 6
Progressive multifocal leukoencephalopathy 1 | 24
Pseudoachondroplasia 1 | 11
Pulmonary lymphangioleiomyomatosis 1 | 5
Renal transplant rejection 1 | 13
Sporotrichosis 1 | 5
Squamous cell carcinoma of esophagus 1 | 82
Tetanus 1 | 66
Toxic encephalopathy 1 | 131
Transplanted organ rejection 1 | 10
Ventricular arrhythmia 1 | 14
Waldenstrons macroglobulinemia 1 | 765
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
atypical teratoid/rhabdoid tumor 1 | 1,095
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 499
chronic rhinosinusitis 1 | 512
colon cancer 1 | 1,475
ductal carcinoma in situ 1 | 1,745
facioscapulohumeral dystrophy 1 | 286
gastric carcinoma 1 | 832
hepatocellular carcinoma 1 | 532
interstitial cystitis 1 | 2,299
interstitial lung disease 1 | 291
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
juvenile dermatomyositis 1 | 1,189
limb girdle muscular dystrophy 2A 1 | 156
lung carcinoma 1 | 2,844
nasopharyngeal carcinoma 1 | 1,056
non-small cell lung cancer 1 | 2,798
pancreatic carcinoma 1 | 567
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
primary pancreatic ductal adenocarcinoma 1 | 1,271
sonic hedgehog group medulloblastoma 1 | 1,482
tuberculosis 1 | 1,557
tuberculosis and treatment for 6 months 1 | 686
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146
Transcription Factor 1 | 1,400

Grant Application

1R01CA142657-01A1 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Peptidyl-prolyl cis-trans isomerase FKBP1A FKBP1A Tclin Enzyme -2.75744 370.6 255
Nuclear factor of activated T-cells, cytoplasmic 3 NFATC3 Tbio Transcription Factor -1.99681 101.3 183
Calmodulin CALM3 Tclin Non-IDG -3.77570 5075.9 259
Secreted frizzled-related protein 2 SFRP2 Tbio Non-IDG -2.10726 143.5 164